Biotage acquires ATDBio for $62M

By The Science Advisory Board staff writers

October 20, 2021 -- Biotage acquired the U.K.-based privately held company ATDBio for $62 million (45 million pounds).

The acquisition adds DNA and RNA oligonucleotide synthesis and purification platforms to Biotage's portfolio. The platforms are used for drug discovery, molecular diagnostics, nucleic acid-based therapeutics, and new generation DNA and RNA sequencing technologies.

This deal is expected to expand and strengthen Biotage as a leading life science tool and impact technology service provider.

Tech Overview - Flash Chromatography
Today’s focus will be on flash chromatography, a special type of column chromatography. Flash chromatography is a preparative liquid chromatography method...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter